-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LfrExYLmcVhNJbvXAfx7y+Utzqyg6ziGZmORSQdFthXCZ8Jtoq15AaeJIlG5FTIb WBYMMEVhoeAkqpQEvu6fLQ== 0001467468-09-000001.txt : 20090701 0001467468-09-000001.hdr.sgml : 20090701 20090701125240 ACCESSION NUMBER: 0001467468-09-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090701 DATE AS OF CHANGE: 20090701 EFFECTIVENESS DATE: 20090701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Insight Pharmaceuticals Corp CENTRAL INDEX KEY: 0001467468 IRS NUMBER: 943375238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1208 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-132367 FILM NUMBER: 09921499 BUSINESS ADDRESS: STREET 1: 1170 WHEELER WAY, SUITE 150 CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 800-344-7239 MAIL ADDRESS: STREET 1: 1170 WHEELER WAY, SUITE 150 CITY: LANGHORNE STATE: PA ZIP: 19047 D 1 primary_doc.xml X0401 D LIVE 0001467468 Insight Pharmaceuticals Corp 1170 WHEELER WAY, SUITE 150 LANGHORNE PA 19047 800-344-7239 None DELAWARE Corporation true Mickael Tukdarian 1170 Wheeler Way, Suite 150 Langhorne PA 19047 Executive Officer Director Joseph Suprenuk 1170 Wheeler Way, Suite 150 Langhorne PA 19047 Executive Officer Dennis Kinsey 1170 Wheeler Way, Suite 150 Langhorne PA 19047 Executive Officer Craig Hille 1919 Pennsylvania Avenue N.W. 3rd Floor Washington DC 20006 Director Robert Monk 1919 Pennsylvania Avenue N.W. 3rd floor Washington DC 20006 Director Mark Poff 345 California Street, Suite 2550 San Francisco CA 94104 Executive Officer Director C. Morris Stout 345 California Street, Suite 2550 San Francisco CA 94104 Executive Officer Director Daniel C. Reese 345 California Street, Suite 2550 San Francisco CA 94104 Executive Officer Director Other Decline to Disclose 06 false 2009-06-17 false true true Proceeds from sale of securities wre contributed to Issuer's wholly-owned subsidiary for the sole purpose to acquire assets. 0 32300000 32300000 0 false 2 0 0 0 false Insight Pharmaceuticals Corp Mickael Tukdarian Mickael Tukdarian President 2009-06-30 -----END PRIVACY-ENHANCED MESSAGE-----